Eribulin in combination with HER2-targeted antibodies for successful treatment of metastatic salivary duct carcinoma: A report of two cases

被引：2

作者：

Fujimi, Akihito ^{[1
]}

Nagamachi, Yasuhiro ^{[1
]}

Yamauchi, Naofumi ^{[1
]}

Nishisato, Takuji ^{[2
]}

Murase, Kazuyuki ^{[3
]}

Takada, Kohichi ^{[3
]}

Tsujiwaki, Mitsuhiro ^{[4
]}

Sugita, Shintaro ^{[4
]}

Hasegawa, Tadashi ^{[4
]}

Kato, Junji ^{[3
]}

机构：

[1] Sapporo Kiyota Hosp, Dept Hematol, Sapporo, Hokkaido, Japan

[2] Sapporo Kiyota Hosp, Dept Internal Med, Sapporo, Hokkaido, Japan

[3] Sapporo Med Univ, Dept Med Oncol, Sapporo, Hokkaido, Japan

[4] Sapporo Med Univ, Dept Surg Pathol, Sapporo, Hokkaido, Japan

来源：

ORAL ONCOLOGY | 2021年 / 120卷

关键词：

Salivary duct carcinoma; Carcinoma ex pleomorphic adenoma; Head and neck cancer; HER-2; Eribulin; Trastuzumab; Pertuzumab; TRASTUZUMAB; PERTUZUMAB;

D O I：

10.1016/j.oraloncology.2021.105287

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：3

共 11 条

[1] First report of eribulin in combination with pertuzumab and trastuzumab for advanced HER2-positive breast cancer [J].

Araki, Kazuhiro ;

Fukada, Ippei ;

Yanagi, Hiroyo ;

Kobayashi, Kokoro ;

Shibayama, Tomoko ;

Horii, Rie ;

Takahashi, Shunji ;

Akiyama, Futoshi ;

Ohno, Shinji ;

Ito, Yoshinori .

BREAST, 2017, 35 :78-84

[2] A 20-Year Review of 75 Cases of Salivary Duct Carcinoma [J].

Gilbert, Mark R. ;

Sharma, Arun ;

Schmitt, Nicole C. ;

Johnson, Jonas T. ;

Ferris, Robert L. ;

Duvvuri, Umamaheswar ;

Kim, Seungwon .

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2016, 142 (05) :489-495

[3]

Inoue K, 2019, INVEST NEW DRUG, V37, P538, DOI 10.1007/s10637-019-00755-x

[4] Salivary duct carcinoma: Treatment, outcomes, and patterns of failure [J].

Johnston, Meredith L. ;

Huang, Shao Hui ;

Waldron, John N. ;

Atenafu, Eshetu G. ;

Chan, Kelvin ;

Cummings, Bernard J. ;

Gilbert, Ralph W. ;

Goldstein, David ;

Gullane, Patrick J. ;

Irish, Jonathan C. ;

Perez-Ordonez, Bayardo ;

Weinreb, Ilan ;

Bayley, Andrew ;

Cho, John ;

Dawson, Laura A. ;

Hope, Andrew ;

Ringash, Jolie ;

Witterick, Ian J. ;

O'Sullivan, Brian ;

Kim, John .

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 :E820-E826

[5] Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study [J].

Kurzrock, R. ;

Bowles, D. W. ;

Kang, H. ;

Meric-Bernstam, F. ;

Hainsworth, J. ;

Spigel, D. R. ;

Bose, R. ;

Burris, H. ;

Sweeney, C. J. ;

Beattie, M. S. ;

Blotner, S. ;

Schulze, K. ;

Cuchelkar, V ;

Swanton, C. .

ANNALS OF ONCOLOGY, 2020, 31 (03) :412-421

[6] Carcinoma ex pleomorphic adenoma: Pathologic analysis of 73 cases [J].

Lewis, JE ;

Olsen, KD ;

Sebo, TJ .

HUMAN PATHOLOGY, 2001, 32 (06) :596-604

[7] Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignancies [J].

Rodriguez, Cristina P. ;

Martins, Renato G. ;

Baik, Christina ;

Chow, Laura Q. ;

Santana-Davila, Rafael ;

Goulart, Bernardo H. ;

Lee, Sylvia ;

Eaton, Keith D. .

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (03) :584-589

[8] Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma [J].

Takahashi, Hideaki ;

Tada, Yuichiro ;

Saotome, Takashi ;

Akazawa, Kohei ;

Ojiri, Hiroya ;

Fushimi, Chihiro ;

Masubuchi, Tatsuo ;

Matsuki, Takashi ;

Tani, Kaori ;

Osamura, Robert Y. ;

Hirai, Hideaki ;

Yamada, Shuhei ;

Kawakita, Daisuke ;

Miura, Kouki ;

Kamata, Shin-etsu ;

Nagao, Toshitaka .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (02) :125-+

[9] Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification [J].

Takase, Soichiro ;

Kano, Satoshi ;

Tada, Yuichiro ;

Kawakita, Daisuke ;

Shimura, Tomotaka ;

Hirai, Hideaki ;

Tsukahara, Kiyoaki ;

Shimizu, Akira ;

Imanishi, Yorihisa ;

Ozawa, Hiroyuki ;

Okami, Kenji ;

Sato, Yuichiro ;

Sato, Yukiko ;

Fushimi, Chihiro ;

Okada, Takuro ;

Sato, Hiroki ;

Otsuka, Kuninori ;

Watanabe, Yoshihiro ;

Sakai, Akihiro ;

Ebisumoto, Koji ;

Togashi, Takafumi ;

Ueki, Yushi ;

Ota, Hisayuki ;

Hanazawa, Toyoyuki ;

Chazono, Hideaki ;

Osamura, Robert Yoshiyuki ;

Nagao, Toshitaka .

ONCOTARGET, 2017, 8 (35) :59023-59035

[10] Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma [J].

van Boxtel, Wim ;

Boon, Eline ;

Weijs, Willem L. J. ;

van den Hoogen, Frank J. A. ;

Flucke, Uta E. ;

van Herpen, Carla M. L. .

ORAL ONCOLOGY, 2017, 72 :198-200

← 1 2 →